Phase Ib/II trial of TG4001 (Tipapkinogene sovacivec), a therapeutic HPV-vaccine, and Avelumab in patients with recurrent/metastatic HPV16 positive cancers


Christophe Le Tourneau et al.
ESMO 2019
Download the poster here
Poster Presentation